The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine | Zendy

Sivan Gazit | Zendy; Roei Shlezinger | Zendy; Galit Perez | Zendy; Roni Lotan | Zendy; Asaf Peretz | Zendy; Amir BenTov | Zendy; Esma Herzel | Zendy; Hillel Alapi | Zendy; Dani Cohen | Zendy; Khitam Muhsen | Zendy; Gabriel Chodick | Zendy; Tal Patalon | Zendy

Open Access

The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine

Author(s) -

Sivan Gazit,

Roei Shlezinger,

Galit Perez,

Roni Lotan,

Asaf Peretz,

Amir BenTov,

Esma Herzel,

Hillel Alapi,

Dani Cohen,

Khitam Muhsen,

Gabriel Chodick,

Tal Patalon

Publication year - 2022

Publication title -

annals of internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.839

H-Index - 390

eISSN - 1539-3704

pISSN - 0003-4819

DOI - 10.7326/m21-4130

Subject(s) - medicine , hazard ratio , vaccination , randomized controlled trial , incidence (geometry) , cohort study , immunity , clinical trial , cohort , immunology , confidence interval , immune system , physics , optics

There is insufficient evidence regarding the magnitude and durability of protection conferred by a combined effect of naturally acquired immunity after SARS-CoV-2 infection and vaccine-induced immunity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research